Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nikolai Siebert, Maxi Zumpe, Madlen Jüttner, Sascha Troschke-Meurer & Holger N. Lode. (2017) PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD2 antibody ch14.18/CHO. OncoImmunology 6:10.
Read now
Read now
Articles from other publishers (36)
Hailong Tian, Jiangjun Cao, Bowen Li, Edouard C. Nice, Haijiao Mao, Yi Zhang & Canhua Huang. (2023) Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. Bone Research 11:1.
Crossref
Crossref
Mieun Lee-Theilen, Delaine D. Fadini, Julia R. Hadhoud, Fleur van Dongen, Gabriela Kroll, Udo Rolle & Henning C. Fiegel. (2022) Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy. Cancers 14:23, pages 5825.
Crossref
Crossref
Hannah-Lise T. Schofield, Vanessa A. Fabrizio, Suzanne Braniecki, Wendy Pelletier, Hesham Eissa, Beverly Murphy, Joseph Chewning, Karen D. Barton, Leanne M. Embry, John E. Levine, Kirk R. Schultz & Kristin M. Page. (2022) Monitoring Neurocognitive Functioning After Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force. Transplantation and Cellular Therapy 28:10, pages 625-636.
Crossref
Crossref
Amin Daei Sorkhabi, Aila Sarkesh, Ali Fotouhi, Hossein Saeedi & Leili Aghebati‐Maleki. (2022) Cancer combination therapies by silencing of CTLA‐4, PD‐L1, and TIM3 in osteosarcoma. IUBMB Life 74:9, pages 908-917.
Crossref
Crossref
Rosy Njonkou, Christopher M. Jackson, Graeme F. Woodworth & David S. Hersh. (2022) Pediatric glioblastoma: mechanisms of immune evasion and potential therapeutic opportunities. Cancer Immunology, Immunotherapy 71:8, pages 1813-1822.
Crossref
Crossref
Brice Moukengue, Morgane Lallier, Louise Marchandet, Marc Baud’huin, Franck Verrecchia, Benjamin Ory & Francois Lamoureux. (2022) Origin and Therapies of Osteosarcoma. Cancers 14:14, pages 3503.
Crossref
Crossref
Briana E. Heinly & Christa N. Grant. (2022) Cell Adhesion Molecules in Neuroblastoma: Complex Roles, Therapeutic Potential. Frontiers in Oncology 12.
Crossref
Crossref
Aimée du Chatinier, Michaël H Meel, Arvid I Das, Dennis S Metselaar, Piotr Waranecki, Marianna Bugiani, Marjolein Breur, Erin F Simonds, Edbert D Lu, William A Weiss, Juan J Garcia Vallejo, Eelco W Hoving, Timothy N Phoenix & Esther Hulleman. (2022) Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma. Neuro-Oncology Advances 4:1.
Crossref
Crossref
Anders Valind & David Gisselsson. (2021) Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma: What now?. Cancer Reports 4:6.
Crossref
Crossref
Zahra Alipour, Kris Ann P Schultz, Ling Chen, Anne K Harris, Ivan A Gonzalez, John Pfeifer, D Ashley Hill, Mai He & Louis P Dehner. (2021) Programmed Death Ligand 1 Expression and Related Markers in Pleuropulmonary Blastoma. Pediatric and Developmental Pathology 24:6, pages 523-530.
Crossref
Crossref
Xiao Li, Caiping Yan, Dengyuan Wang, Hong Lu & Zhidao Xia. (2021) Fabrication of Micro-Nano Bioactive Glass Scaffold Incorporated with Siglec-15 for Bone Repair and Postoperative Treatment of Osteosarcoma. Science of Advanced Materials 13:8, pages 1445-1451.
Crossref
Crossref
Yi Que, Juan Wang, Jia Zhu, Na Li, Junting Huang, Suying Lu, Feifei Sun, Lian Zhang, Zijun Zhen, Li Zhang, Ruiqing Cai, Haixia Guo, Xiaofei Sun & Yizhuo Zhang. (2021) Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer. Frontiers in Immunology 12.
Crossref
Crossref
Enrico Munari, Francesca R. Mariotti, Linda Quatrini, Pietro Bertoglio, Nicola Tumino, Paola Vacca, Albino Eccher, Francesco Ciompi, Matteo Brunelli, Guido Martignoni, Giuseppe Bogina & Lorenzo Moretta. (2021) PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects. International Journal of Molecular Sciences 22:10, pages 5123.
Crossref
Crossref
Katia Perruccio, Angela Mastronuzzi, Marco Lupattelli, Francesco Arcioni, Ilaria Capolsini, Carla Cerri, Grazia M. I. Gurdo, Maria Speranza Massei, Elena Mastrodicasa & Maurizio Caniglia. (2021) Targeted Therapy with Sirolimus and Nivolumab in a Child with Refractory Multifocal Anaplastic Ependymoma. Reports 4:2, pages 12.
Crossref
Crossref
Chenglong Chen, Lu Xie, Tingting Ren, Yi Huang, Jie Xu & Wei Guo. (2021) Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs. Cancer Letters 500, pages 1-10.
Crossref
Crossref
Taranom Mobasheri, Elham Rayzan, Mahsima Shabani, Mina Hosseini, Ghanbar Mahmoodi Chalbatani & Nima Rezaei. (2020) Neuroblastoma‐targeted nanoparticles and novel nanotechnology‐based treatment methods. Journal of Cellular Physiology 236:3, pages 1751-1775.
Crossref
Crossref
Neil Patel & Abby Green. 2021. Pediatric Transplant and Oncology Infectious Diseases. Pediatric Transplant and Oncology Infectious Diseases
22
33.e3
.
Rachael L. Terry, Deborah Meyran, David S. Ziegler, Michelle Haber, Paul G. Ekert, Joseph A. Trapani & Paul J. Neeson. (2020) Immune profiling of pediatric solid tumors. Journal of Clinical Investigation 130:7, pages 3391-3402.
Crossref
Crossref
Manuel A Silva, Nicolas Triltsch, Simon Leis, Ivan Kanchev, Tze Heng Tan, Benjamine Van Peel, Marian Van Kerckhoven, Vanessa Deschoolmeester & Johannes Zimmermann. (2020) Biomarker recommendation for PD‐1/PD‐L1 immunotherapy development in pediatric cancer based on digital image analysis of PD‐L1 and immune cells. The Journal of Pathology: Clinical Research 6:2, pages 124-137.
Crossref
Crossref
Lihong Wang-Bishop, Mohamed Wehbe, Daniel Shae, Jamaal James, Benjamin C. Hacker, Kyle Garland, Plamen P. Chistov, Marjan Rafat, Justin M. Balko & John T. Wilson. (2020) Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma. Journal for ImmunoTherapy of Cancer 8:1, pages e000282.
Crossref
Crossref
I. V. Proleskovskaya, N. E. Konoplya & O. I. Bydanov. (2020) Treatment of relapse/progression of the disease in patients with neuroblastoma in the Republic of Belarus over a 20-year period: a cohort study. Russian Journal of Pediatric Hematology and Oncology 6:4, pages 40-47.
Crossref
Crossref
Anna Gabrych, Rafał Pęksa, Michał Kunc, Małgorzata Krawczyk, Ewa Izycka-Swieszewska, Wojciech Biernat & Ewa Bień. (2019) The PD-L1/PD-1 axis expression on tumor-infiltrating immune cells and tumor cells in pediatric rhabdomyosarcoma. Pathology - Research and Practice 215:12, pages 152700.
Crossref
Crossref
Brian Hutzen, Siddhi Nath Paudel, Meisam Naeimi Kararoudi, Kevin A. Cassady, Dean A. Lee & Timothy P. Cripe. (2019) Immunotherapies for pediatric cancer: current landscape and future perspectives. Cancer and Metastasis Reviews 38:4, pages 573-594.
Crossref
Crossref
Klaus Rose & Philip D. Walson. (2019) Are Regulatory Age Limits in Pediatric Melanoma Justified?. Current Therapeutic Research 90, pages 113-118.
Crossref
Crossref
Daniel A. Morgenstern & Meredith S. Irwin. 2019. Neuroblastoma. Neuroblastoma
263
281
.
Chiara Camisaschi, Salvatore Lorenzo Renne, Valeria Beretta, Francesca Rini, Rosalin Dolores Spagnuolo, Alessandra Tuccitto, Marta Giorgia Podda, Giorgio Parmiani, Licia Rivoltini, Paola Collini, Chiara Castelli & Roberto Luksch. (2018) Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients. BMC Cancer 18:1.
Crossref
Crossref
Takahiro Shimizu, Yasushi Fuchimoto, Hajime Okita, Kazumasa Fukuda, Yuko Kitagawa, Shigeru Ueno & Tatsuo Kuroda. (2018) A curative treatment strategy using tumor debulking surgery combined with immune checkpoint inhibitors for advanced pediatric solid tumors: An in vivo study using a murine model of osteosarcoma. Journal of Pediatric Surgery 53:12, pages 2460-2464.
Crossref
Crossref
Mary Frances Wedekind, Nicholas L. Denton, Chun-Yu Chen & Timothy P. Cripe. (2018) Pediatric Cancer Immunotherapy: Opportunities and Challenges. Pediatric Drugs 20:5, pages 395-408.
Crossref
Crossref
Mary F. Wedekind, Lars M. Wagner & Timothy P. Cripe. (2018) Immunotherapy for osteosarcoma: Where do we go from here?. Pediatric Blood & Cancer 65:9, pages e27227.
Crossref
Crossref
Lori A. Ramkissoon, Nicholas Britt, Alexander Guevara, Emily Whitt, Eric Severson, Pratheesh Sathyan, Laurie Gay, Julia Elvin, Jeffrey S. Ross, Charlotte Brown, Kimberly Stogner-Underwood, Ryan Mott, David Kram, Roy Strowd, Glenn J. Lesser & Shakti H. Ramkissoon. (2018) Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas. Current Treatment Options in Oncology 19:8.
Crossref
Crossref
Ricardo L. Pereira, Isis C. Nascimento, Ana P. Santos, Isabella E.Y. Ogusuku, Claudiana Lameu, Günter Mayer & Henning Ulrich. (2018) Aptamers: novelty tools for cancer biology. Oncotarget 9:42, pages 26934-26953.
Crossref
Crossref
Xuyao Zhang, Wei Chen, Jiajun Fan, Shaofei Wang, Zongshu Xian, Jingyun Luan, Yubin Li, Yichen Wang, Yanyang Nan, Man Luo, Song Li, Wenzhi Tian & Dianwen Ju. (2018) Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma. Carcinogenesis 39:5, pages 689-699.
Crossref
Crossref
Vanessa P. Tolbert & Katherine K. Matthay. (2018) Neuroblastoma: clinical and biological approach to risk stratification and treatment. Cell and Tissue Research 372:2, pages 195-209.
Crossref
Crossref
Akira Nakagawara, Yuanyuan Li, Hideki Izumi, Katsumi Muramori, Hiroko Inada & Masanori Nishi. (2018) Neuroblastoma. Japanese Journal of Clinical Oncology 48:3, pages 214-241.
Crossref
Crossref
Nai-Kong V. Cheung & Estibaliz Lopez-Rodrigo. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Clare F. Malone & Kimberly Stegmaier. (2017) Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma. Cancer Cell 32:3, pages 271-273.
Crossref
Crossref